1
Alotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer
Condition(s):SCLC, Extensive StageLast Updated:April 12, 2022Recruiting
Small Cell Lung Carcinoma: 1316 Clinical Trials, Page 1 of 132
Hide Studies Not Open or Pending
2
Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma
Condition(s):Small Cell Lung CancerLast Updated:August 16, 2021Recruiting
3
Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)
Condition(s):Small-cell Lung Cancer; Extensive-stage Small-cell Lung Cancer; Lung CancerLast Updated:March 28, 2022Not yet recruiting
4
Transformation Into Small Cell Lung Cancer : a Mode of Resistance to Treatment
Condition(s):Small Cell Lung CancerLast Updated:February 1, 2018Completed
5
Feasibility and Safety Study of Nivolumab With Irinotecan for Small Cell Lung Cancer
Condition(s):Small-cell Lung Cancer; Small Cell Lung CarcinomaLast Updated:June 14, 2022Terminated
6
A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung Cancer
Condition(s):Small Cell Lung CarcinomaLast Updated:October 24, 2017Completed
7
Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
Condition(s):Small-cell Lung CancerLast Updated:February 21, 2022Recruiting
8
A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma
Condition(s):Extensive Stage Small Cell Lung CarcinomaLast Updated:July 23, 2019Completed
9
Selinexor in Treating Patients With Relapsed Small Cell Lung Cancer
Condition(s):Recurrent Small Cell Lung CarcinomaLast Updated:May 16, 2016Terminated
10
PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)
Condition(s):Limited Stage Small Cell Lung Cancer; Extensive-stage Small-cell Lung CancerLast Updated:June 10, 2022Not yet recruiting